Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Other financing activities (2021 - 2025)

Historic Other financing activities for P3 Health Partners (PIII) over the last 3 years, with Q3 2025 value amounting to -$7000.0.

  • P3 Health Partners' Other financing activities fell 10700.0% to -$7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $177000.0, marking a year-over-year increase of 7700.0%. This contributed to the annual value of $103000.0 for FY2024, which is 4046.24% down from last year.
  • Per P3 Health Partners' latest filing, its Other financing activities stood at -$7000.0 for Q3 2025, which was down 10700.0% from $42000.0 recorded in Q2 2025.
  • In the past 5 years, P3 Health Partners' Other financing activities registered a high of $6.4 million during Q2 2021, and its lowest value of -$6.3 million during Q3 2021.
  • For the 3-year period, P3 Health Partners' Other financing activities averaged around $72444.4, with its median value being $42000.0 (2025).
  • Over the last 5 years, P3 Health Partners' Other financing activities had its largest YoY gain of 10700.0% in 2025, and its largest YoY loss of 10700.0% in 2025.
  • Over the past 3 years, P3 Health Partners' Other financing activities (Quarter) stood at $7972.0 in 2021, then plummeted by 62.37% to $3000.0 in 2024, then crashed by 333.33% to -$7000.0 in 2025.
  • Its last three reported values are -$7000.0 in Q3 2025, $42000.0 for Q2 2025, and $139000.0 during Q1 2025.